Medicines Formulary

Medicines A–Z

I

Drug name	NICE TAs	Comments
Indometacin M/R capsules		For gout and resistant case
Indometacin suspension (100ml)		For gout and resistant case
Infanrix-IPV		Supported with PGD
Infliximab	TA329 - Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
Infliximab injection (Remicade®, Inflectra®, Remsima®)	TA199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA195 - Drugs for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA143 - Adalimumab , etanercept and infliximab for ankylosing spondylitis TA130 - Adalimumab , etanercept and infliximab for the treatment of rheumatoid arthritis TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
Infliximab	TA134 - Infliximab for the treatment of adults with psoriasis
Influenza vaccine (Fluenz®)		As per Green book, Health Service Circular, National Flu campaign/service. For intranasal use in children aged 2 years to under 18 years in lin eiwht national flu vaccination programme, Supported with PGD.
Influenza vaccine (Intanza®)		For intradermal use only, Supported with PGD.
Influenza vaccine (trivalent seaonsal) (Agrippal®, Enzira®, Fluarix®, Fluvirin®, Imuvac®) (Influvac Desu®, Viroflu®)		As per Green book, Health Service Circular, National Flu campaign/service. Supported with PGD.
Influenza vaccine inactivated split viron BP		As per Green book, Health Service Circular, National Flu campaign/service

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.